| Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban |
18 |
| Pathogenesis and diagnosis of disseminated intravascular coagulation |
17 |
| Laboratory diagnosis of heparin-induced thrombocytopenia |
15 |
| Quantification of NETs-associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis |
12 |
| An update on laboratory assessment for direct oral anticoagulants (DOACs) |
10 |
| Molecular diagnostic update in hereditary hemolytic anemia and neonatal hyperbilirubinemia |
10 |
| Digital morphology analyzers in hematology: ICSH review and recommendations |
10 |
| Image processing and machine learning in the morphological analysis of blood cells |
10 |
| Osmotic gradient ektacytometry: A valuable screening test for hereditary spherocytosis and other red blood cell membrane disorders |
9 |
| Impact of four direct oral anticoagulants on rotational thromboelastometry (ROTEM) |
9 |
| Extended persistence of antiphospholipid antibodies beyond the 12-week time interval: Association with baseline antiphospholipid antibodies titres |
9 |
| Update on diagnostic testing for platelet function disorders: What is practical and useful? |
9 |
| Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia |
9 |
| Electron microscopy examination of platelet whole mount preparations to quantitate platelet dense granule numbers: Implications for diagnosing suspected platelet function disorders due to dense granule deficiency |
8 |
| The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays |
8 |
| Advantages, disadvantages and optimization of one-stage and chromogenic factor activity assays in haemophilia A and B |
8 |
| New challenges and best practices for the laboratory monitoring of factor VIII and factor IX replacement |
7 |
| How I investigate for bleeding disorders |
7 |
| How I investigate monocytosis |
7 |
| High-throughput sequencing for diagnosing platelet disorders: lessons learned from exploring the causes of bleeding disorders |
7 |
| Immature granulocytes index as early marker of sepsis |
7 |
| Recent advances in cytogenetic characterization of multiple myeloma |
7 |
| The clinical utility of new reticulocyte and erythrocyte parameters on the Sysmex XN 9000 for iron deficiency in pregnant patients |
7 |
| Machine learning applications in the diagnosis of leukemia: Current trends and future directions |
7 |
| Clotting and chromogenic factor VIII assay variability in post-infusion and spiked samples containing full-length recombinant FVIII or recombinant factor VIII Fc fusion protein (rFVIIIFc) |
7 |
| Use of D-dimer in oral anticoagulation therapy |
6 |
| Sickle cell disease: Reducing the global disease burden |
6 |
| Semi-automated von Willebrand factor multimer assay for von Willebrand disease: Further validation, benefits and limitations |
6 |
| Digital microscopy as a screening tool for the diagnosis of hereditary hemolytic anemia |
6 |
| Optimizing morphology through blood cell image analysis |
6 |
| Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors |
6 |
| The importance of commutability in material used for quality control purposes |
5 |
| Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay |
5 |
| Factor XIII deficiency diagnosis: Challenges and tools |
5 |
| Digital droplet PCR-based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantation |
5 |
| Abnormal scattergrams and cell population data generated by fully automated hematological analyzers: New tools for screening malaria infection? |
5 |
| Flow cytometric osmotic fragility test and eosin-5 '-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis |
5 |
| Prenatal and preimplantation diagnosis of hemoglobinopathies |
5 |
| The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms |
5 |
| Flow cytometry data analysis: Recent tools and algorithms |
5 |
| Evaluating the analytical performance of five new coagulation assays for the measurement of prothrombin time and activated thromboplastin time |
5 |
| Easy discrimination of hematogones from lymphoblasts in B-cell progenitor acute lymphoblastic leukemia patients using CD81/CD58 expression ratio |
5 |
| A CBC algorithm combined with immature platelet fraction is able to identify JAK2 V617F mutation-positive polycythaemia vera patients |
4 |
| Vitamin B12 deficiency and clinical laboratory: Lessons revisited and clarified in seven questions |
4 |
| Acute myeloid leukaemia: How to combine multiple tools |
4 |
| Optimal wavelength for the clot waveform analysis: Determination of the best resolution with minimal interference of the reagents |
4 |
| Establishment of reference intervals for complete blood count parameters in venous blood for children in the Xiamen area, China |
4 |
| Evaluation of an automated algorithm for interpretation of lupus anticoagulant testing |
4 |
| Molecular prevalence of thalassemia and hemoglobinopathies among the Lao Loum Group in the Lao People's Democratic Republic |
4 |
| The association of HBG BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease |
4 |
